OxyContin was delisted from Canadian provincial drug formularies in March 2012 and replaced with a reformulated tamper-resistant form of oxycodone. British Columbia Centre on Substance use et al found this did not reduceĀ unregulated opioid use by people with opioid use disorder and “highlights unintended consequences of supply-reduction interventions”.


